WO1996029112A1 - Systeme d'acces vasculaire - Google Patents

Systeme d'acces vasculaire Download PDF

Info

Publication number
WO1996029112A1
WO1996029112A1 PCT/US1996/003814 US9603814W WO9629112A1 WO 1996029112 A1 WO1996029112 A1 WO 1996029112A1 US 9603814 W US9603814 W US 9603814W WO 9629112 A1 WO9629112 A1 WO 9629112A1
Authority
WO
WIPO (PCT)
Prior art keywords
catheter
cannula
port
head
access
Prior art date
Application number
PCT/US1996/003814
Other languages
English (en)
Inventor
Gerald S. Melsky
Original Assignee
Therex Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therex Corporation filed Critical Therex Corporation
Priority to EP96909798A priority Critical patent/EP0814865A1/fr
Priority to AU53182/96A priority patent/AU5318296A/en
Priority to JP8528598A priority patent/JPH11514248A/ja
Publication of WO1996029112A1 publication Critical patent/WO1996029112A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02—Access sites
    • A61M39/0208—Subcutaneous access sites for injecting or removing fluids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02—Access sites
    • A61M39/0208—Subcutaneous access sites for injecting or removing fluids
    • A61M2039/0211—Subcutaneous access sites for injecting or removing fluids with multiple chambers in a single site

Definitions

  • This invention relates to a vascular access system. It relates more particularly to a vascular access device and associated access needle which facilitate hemapheresis.
  • blood is withdrawn from the patient's vasculature using a needle attached to a tube leading to a centrifuge.
  • the centrifuge separates the blood plasma from the other blood components which are then mixed with fresh plasma and returned to the patient's body via a second tube and needle. In some cases, this procedure must be repeated as often as twelve times per month.
  • an external catheter is often used as the principle hemapheresis access.
  • the catheter consists of a tube, generally of silicone rubber, having a round or oval crossection and two lumens.
  • the distal end of the catheter resides in the patient's vasculature. A common location for that end is the superior vena cava.
  • the proximal end of the catheter lies outside the patient's skin so that it is accessible by medical personnel performing the procedure. That end is usually fitted with Luer connectors for coupling the catheter to conduits leading to the external separating machine that processes the patient's blood.
  • the connectors at the proximal end of the catheter while offering a "needle free" means of connecting the patient to the external machine, are difficult to maintain in a sterile condition. Once these connectors become contaminated, the organisms may be transmitted to the patient during the procedure. Also, even though these catheters are flushed with heparinized solutions after each use, their lumens frequently become occluded with thrombus. This is due, in part, to blood being drawn into the lumens in order to make up for the volume of fluid lost by the process of diffusion through the wall of that segment of the catheter which resides outside of the patient.
  • implantable dual-chamber vascular access devices have been developed which provide direct access to the vascular system of a patient receiving extracorporeal blood treatment.
  • Such devices' are disclosed in patent 5,041 ,098.
  • One embodiment comprises a head consisting of a pair of ports joined at their peripheries. Each port has an internal chamber and a self-sealing septum spanning the open face of the chamber to establish a closed reservoir within the port.
  • a tubular cannula extends from the side wall of each port to establish fluid communication between the reservoir and an external catheter leading to the infusion site.
  • each catheter is permanently connected to a coupling member which is releasably connected to the corresponding port's outlet cannula by means of a coupler.
  • the distal ends of the two catheters are usually cut to length so that the two lumens terminate about one inch apart. Also, in some cases, there may be side openings adjacent the ends of the catheters.
  • That prior device is surgically implanted within the patient's body so that the catheters access the vasculature through a major vessel such as the subclavian vein.
  • the head is surgically implanted within the body, e.g., in a pocket in the musculature of the chest, and the proximal ends of the catheters are tunneled to this pocket and connected to the head using the couplers.
  • That known device is accessed by inserting hypodermic needles connected to the external machine through the septa into the internal chambers of the two ports. Blood is withdrawn from the vasculature through one port and introduced or re-introduced into the vasculature through the other port.
  • Vascular access devices typified by the ones in the above patent are disad v antaged in that they allow only relatively low blood flow rates. This is because in order for the devices' septa to reseal, they must be penetrated by relatively small needles, i.e., 19 gauge or smaller diameter. Larger gauge needles result in coring of the septa and reduced puncture life. Such coring would require that the prior devices be replaced relatively often.
  • the prior devices of this general type are disadvantaged also because their outlet catheters have to be customized to the patient prior to implantation of the device. More particularly, the distance between the implantation site for the head, e.g., the subclavean pocket, and the infusion site, e.g., the superior vena cava, may vary from patient to patient depending upon the patient's size. Since the proximal end of the catheter is permanently fixed to the head itself or to a coupling member that is connected to the head, the critical distance for a given patient must be measured and the catheter cut to the proper length and permanently connected to the coupling member prior to implantation.
  • the alternative is to utilize an access device having an unnecessarily long catheter and to accommodate the extra catheter length as a meandering or fold within the body.
  • this results in an unwanted increase in the fluid flow resistance of the device.
  • Another object of the invention is to provide a device of this type which has a relatively long useful life.
  • the present system comprises an implantable vascular access device and associated needle for use in the extracorporial treatment of blood or fractions thereof.
  • the device includes dual access ports, each port having an internal chamber defined by the side and bottom walls of the port.
  • a self-sealing, needle-penetrable septum closes the open top of each chamber.
  • Each septum is quite thick, being dome shaped so it protrudes from the top of the corresponding port. Consequently, when the device is implanted, the septa are relatively easy to locate. More importantly, the septa are not prone to leakage even after being penetrated a relatively large number of times by a relatively large diameter needle.
  • a separate outlet cannula extends from each port.
  • the proximal end of each cannula is in fluid communication with the chamber in the corresponding port.
  • the opposite or distal end of each cannula is barbed so that the proximal end of a flexible resilient catheter can be engaged tightly over the barbed end.
  • the outlet cannula of each port carries a locking collar which can be slid over the proximal end of the catheter to hold that end in place and to provide stress relief at that location.
  • the two catheters associated with the two ports of the present access device are normally joined together along their lengths so that they form a unitary dual-lumen catheter.
  • the two catheters sections, or at least their proximal end segments are separable much like the two insulated conductors of a standard lamp cord, so that the two catheter sections can be separated by pulling them apart.
  • the head When the device is implanted, the head is positioned in a sub ⁇ cutaneous pocket made by blunt dissection of tissue just below the clavicle.
  • the distal end of the catheter is positioned at the junction of the superior vena cava and the ventricular atrium by accessing the subclavean or jugular vein.
  • the proximal end of the catheter is then tunneled to the pocket containing the head and trimmed so that it just reaches the head.
  • the proximal ends of the catheter sections are pulled apart and engaged over the outlet cannulas of the two ports comprising the head and locked in place with the locking collars.
  • its dual-lumen outlet catheter can be cut to exactly the right length to span the distance between the head and the infusion site for that particular patient.
  • the catheter presents a minimum flow resistance to fluid flow for that particular patient without having to be customized ahead of time to that patient.
  • the system also includes an especially large needle, i.e., 16 gauge or less, to be described in more detail later for accessing the device.
  • the needle has a hub and a stylet which occludes the lumen of the needle cannula during insertion of the needle through a septum of the access device. With the stylet in place, the needle can penetrate the septum without coring the septum material. Once the needle is in place, the stylet may be removed and the hub of the needle cannula connected to a line leading to an external blood separation machine.
  • FIG. 1 is an isometric view with parts broken away showing a vascular access device for hemapheresis incorporating the invention
  • FIGS. 2A to 2C are diagrammatic views illustrating the operation of the overall vascular access system.
  • our vascular access system comprises a head 10 connected to a catheter 11.
  • the head includes a pair of substantially identical ports 10a and 10b joined at their peripheries.
  • Each port has a bottom wall 12 and a generally cylindrical side wall 14 extending up from the bottom wall so as to form an internal chamber 16 having an open mouth 18.
  • a conical groove 22 is inscribed in the interior surface of wall 14 adjacent to mouth 18 for seating a needle-penetrable self-sealing septum 24.
  • Septum 24 is "shoe-horned" into the mouth 18 so that its inner edge seats on the inner wall 22a of groove 22 and so that the outer edge of 22b of that groove overhangs the septum, thereby retaining the septum 24 in place so that the septum spans mouth 18.
  • Septum 24 has a rounded, raised central portion or dome 24a which protrudes from mouth 18.
  • the raised portions 24a of septa 24 can be felt under the skin so that needles can be aimed properly at the septa. Also, the extra thickness of the domed septa makes them less prone to leakage.
  • each port 10a, 10b is provided with a bottom flange 26 having suture holes 28 spaced around the flange so that when the head 10 is implanted in the body, it can be sutured to adjacent tissue.
  • An outlet cannula 32 extends from the side wall 14 of each port 10a,. 10b.
  • Each cannula 32 is in fluid communication with the internal chamber 16 of the corresponding port and the outer end of each cannula is barbed at 32a.
  • each cannula 32 carries a locking sleeve 34 which is slidable along that cannula between an extended position shown in FIG.
  • each sleeve 34 is slitt ⁇ d to form a circular array of flexible, resilient tines 34a.
  • the free ends of the tines have inwardly extending ribs 36 which are arranged to engage in a circular groove 38 inscribed in the corresponding cannula 32 to releasably maintain sleeve 34 in its extended position shown in FIG. 1.
  • Outlet catheter 11 is composed of two sections 11a and 11b which are joined together along their lengths, but which are separable by pulling the two sections apart.
  • the proximal end of the catheter is squared off and the two sections 11a and 11b are pulled apart a sufficient amount to enable the proximal end of catheter section 11a to be engaged over the outlet cannula 32 of port 10a and to enable the similar end of catheter section 11b to be slid onto the outlet cannula 32 of port 10b.
  • the two locking sleeves 34 are moved to their extended positions to secure the proximal ends of the catheter sections to their respective ports and to provide stress relief for the catheter.
  • the distal end of the catheter 11 is designed so that the exit points of the two catheter sections are spaced apart from one another by about 1 inch. This helps to reduce unwanted re-circulation of blood returning to the patient's vasculature via one catheter section being drawn back immediately into the other catheter section.
  • the distal ends of the two catheter sections 11a and 11 b may also be provided with one or more side ports 38 to maximize blood flow through the device.
  • Needle 42 includes a relatively large diameter cannula 44, e.g., 12 to 16 gauge, having a stylet or obturator 46 which occludes the lumen of the cannula when the needle is inserted through septum 24 into port 10a or 10b. With the stylet in place, the needle cannula may penetrate septum 24 through the skin S as shown in FIG. 3A without coring the septum.
  • cannula 44 e.g., 12 to 16 gauge
  • stylet or obturator 46 which occludes the lumen of the cannula when the needle is inserted through septum 24 into port 10a or 10b.
  • the needle cannula may penetrate septum 24 through the skin S as shown in FIG. 3A without coring the septum.
  • the stylet 46 is provided with a hub 52 at its proximal end which releasably engages to a connector or hub 54 at the proximal end of the cannula 44.
  • the hub 52 may be de-coupled from connector 54 and the stylet 46 withdrawn from the cannula as illustrated in FIG. 2B.
  • connector 54 may be coupled to a mating connector 56 attached to the end of a tube 58 connected to the external machine as shown in FIG. 2C.
  • Surgical placement of the illustrated device is similar to that of other conventional access devices. More particularly, the catheter 11 is implanted under the skin S so that its distal end lies at the junction of the superior vena cava with the ventricular atrium. This may be accomplished by accessing the sub-clavean or jugular vein either by the Seldinger technique or by a direct cut-down. A kit containing a peel-away introducer/dilator, along with a guide wire and Seldinger needle, may be provided to facilitate the Seldinger procedure.
  • the head 10 may be implanted in a subcutaneous pocket made by blunt dissection of the tissue below the clavicle. Then, the proximal end of the catheter is tunneled to this pocket, trimmed and connected to the port head.
  • the catheter 11 is designed so that the end of the catheter proximal to the head may be cut to the correct length and bifurcated by hand so that the two branches may be securely attached to the head's two outlet cannulas 32.
  • the catheter 11 may be trimmed at the time of implant so that is has the shortest possible length consistent with proper head placement in the patient, thus minimizing flow resistance.
  • the head 10 After the head 10 is implanted, it may be accessed as described above using needle 42 which, because of its relatively large diameter, also minimizes fluid flow resistance in the system.
  • the needle cannula 44 contains the stylet 46 during the needle insertion process, there is minimum coring of the head's septa 24. That and the thickness of septa 24 enable each port to be accessed many times without leaking. Therefore, the device should be able to remain implanted for a long period of time.

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • External Artificial Organs (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

Système d'accès vasculaire pourvu d'une tête implantable qui comporte une paire d'orifices d'accès similaires, dont chacun comporte une chambre interne avec une embouchure ouverte, une canule de sortie s'étendant depuis l'orifice et étant en communication fluide avec la chambre correspondante, et une cloison bombée fermant l'embouchure de la chambre correspondante. Un cathéter souple à deux lumières est relié à la tête. Il comporte une paire de lumières parallèles solidaires faiblement écartées qui peuvent se séparer, de sorte que l'extrémité proximale du cathéter peut être raccordée aux canules de sortie de la tête, la canule de sortie d'un orifice venant se loger dans l'une des lumières du cathéter et celle de l'autre orifice dans l'autre lumière. Des manchons de fixation sont ménagés sur la tête afin de bloquer les canules de sortie dans leur lumière de cathéter respective, et une aiguille d'accès spécial permet d'avoir accès à la tête afin d'éviter d'en percer les cloisons.
PCT/US1996/003814 1995-03-21 1996-03-21 Systeme d'acces vasculaire WO1996029112A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP96909798A EP0814865A1 (fr) 1995-03-21 1996-03-21 Systeme d'acces vasculaire
AU53182/96A AU5318296A (en) 1995-03-21 1996-03-21 Vascular access system
JP8528598A JPH11514248A (ja) 1995-03-21 1996-03-21 血管アクセス装置

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40716695A 1995-03-21 1995-03-21
US08/407,166 1995-03-21

Publications (1)

Publication Number Publication Date
WO1996029112A1 true WO1996029112A1 (fr) 1996-09-26

Family

ID=23610911

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1996/003814 WO1996029112A1 (fr) 1995-03-21 1996-03-21 Systeme d'acces vasculaire

Country Status (5)

Country Link
EP (1) EP0814865A1 (fr)
JP (1) JPH11514248A (fr)
AU (1) AU5318296A (fr)
CA (1) CA2222142A1 (fr)
WO (1) WO1996029112A1 (fr)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1154814A1 (fr) * 1999-01-27 2001-11-21 Vasca, Inc. Systeme d'acces et procedes faisant intervenir des canules reversibles
WO2002062288A1 (fr) 2001-02-02 2002-08-15 Baxter International Inc. Dispositif de reconstitution et son procede d'utilisation
US9731104B2 (en) 2010-04-23 2017-08-15 Medical Components, Inc. Implantable dual reservoir access port
CN109107020A (zh) * 2018-09-18 2019-01-01 中山肾康医疗科技有限公司 一种用于血液透析动静脉穿刺的皮下埋藏式穿刺装置
WO2019200304A1 (fr) * 2018-04-13 2019-10-17 C.R. Bard, Inc. Dispositif d'accès vasculaire simple et double à profil bas
US10463845B2 (en) 2013-01-23 2019-11-05 C.R. Bard, Inc. Low-profile access port
USD870264S1 (en) 2017-09-06 2019-12-17 C. R. Bard, Inc. Implantable apheresis port
CN114375214A (zh) * 2019-07-09 2022-04-19 门户通达公司 肘节式脉管进入端口
US11420033B2 (en) 2013-01-23 2022-08-23 C. R. Bard, Inc. Low-profile single and dual vascular access device
US11464960B2 (en) 2013-01-23 2022-10-11 C. R. Bard, Inc. Low-profile single and dual vascular access device
US11903873B2 (en) * 2017-08-30 2024-02-20 Mani, Inc. Infusion pipe

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4967183B2 (ja) * 2000-09-22 2012-07-04 株式会社ジェイ・エム・エス 動脈または静脈ライン採血システム用採血デバイス、および該採血デバイスを使用した動脈または静脈ライン採血システム。

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405313A (en) * 1982-01-29 1983-09-20 Sisley James R Figure-eight, dual-lumen catheter and method of using
US4861341A (en) * 1988-07-18 1989-08-29 Woodburn Robert T Subcutaneous venous access device and needle system
EP0343910A2 (fr) * 1988-05-26 1989-11-29 Infusaid, Inc. Cathéter avec connexion par clipsage pour un dispositif implantable
US5041098A (en) * 1989-05-19 1991-08-20 Strato Medical Corporation Vascular access system for extracorporeal treatment of blood
US5167638A (en) * 1989-10-27 1992-12-01 C. R. Bard, Inc. Subcutaneous multiple-access port
EP0583049A1 (fr) * 1992-08-10 1994-02-16 Robert E. Fischell Aiguille d'accès vasculaire
WO1994005246A1 (fr) * 1992-09-04 1994-03-17 Michigan Transtech Corporation Dispositif d'acces implantable

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405313A (en) * 1982-01-29 1983-09-20 Sisley James R Figure-eight, dual-lumen catheter and method of using
EP0343910A2 (fr) * 1988-05-26 1989-11-29 Infusaid, Inc. Cathéter avec connexion par clipsage pour un dispositif implantable
US4861341A (en) * 1988-07-18 1989-08-29 Woodburn Robert T Subcutaneous venous access device and needle system
US5041098A (en) * 1989-05-19 1991-08-20 Strato Medical Corporation Vascular access system for extracorporeal treatment of blood
US5167638A (en) * 1989-10-27 1992-12-01 C. R. Bard, Inc. Subcutaneous multiple-access port
EP0583049A1 (fr) * 1992-08-10 1994-02-16 Robert E. Fischell Aiguille d'accès vasculaire
WO1994005246A1 (fr) * 1992-09-04 1994-03-17 Michigan Transtech Corporation Dispositif d'acces implantable

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1154814A1 (fr) * 1999-01-27 2001-11-21 Vasca, Inc. Systeme d'acces et procedes faisant intervenir des canules reversibles
EP1154814A4 (fr) * 1999-01-27 2002-03-20 Vasca Inc Systeme d'acces et procedes faisant intervenir des canules reversibles
WO2002062288A1 (fr) 2001-02-02 2002-08-15 Baxter International Inc. Dispositif de reconstitution et son procede d'utilisation
US9731104B2 (en) 2010-04-23 2017-08-15 Medical Components, Inc. Implantable dual reservoir access port
US10485964B2 (en) 2010-04-23 2019-11-26 Medical Components, Inc. Implantable dual reservoir access port
US10463845B2 (en) 2013-01-23 2019-11-05 C.R. Bard, Inc. Low-profile access port
US11420033B2 (en) 2013-01-23 2022-08-23 C. R. Bard, Inc. Low-profile single and dual vascular access device
US11464960B2 (en) 2013-01-23 2022-10-11 C. R. Bard, Inc. Low-profile single and dual vascular access device
US11903873B2 (en) * 2017-08-30 2024-02-20 Mani, Inc. Infusion pipe
USD870264S1 (en) 2017-09-06 2019-12-17 C. R. Bard, Inc. Implantable apheresis port
USD885557S1 (en) 2017-09-06 2020-05-26 C. R. Bard, Inc. Implantable apheresis port
WO2019200304A1 (fr) * 2018-04-13 2019-10-17 C.R. Bard, Inc. Dispositif d'accès vasculaire simple et double à profil bas
CN109107020A (zh) * 2018-09-18 2019-01-01 中山肾康医疗科技有限公司 一种用于血液透析动静脉穿刺的皮下埋藏式穿刺装置
CN114375214A (zh) * 2019-07-09 2022-04-19 门户通达公司 肘节式脉管进入端口
CN114375214B (zh) * 2019-07-09 2024-03-29 门户通达公司 肘节式脉管进入端口

Also Published As

Publication number Publication date
EP0814865A1 (fr) 1998-01-07
CA2222142A1 (fr) 1996-09-26
JPH11514248A (ja) 1999-12-07
AU5318296A (en) 1996-10-08

Similar Documents

Publication Publication Date Title
US5931829A (en) Methods and systems for establishing vascular access
EP1019142B1 (fr) Ensemble d'orifice d'accès adaptable à un fil-guide
US6962577B2 (en) Implantable hemodialysis access device
US6682498B2 (en) Methods and systems for subcutaneous graft implantation
US7261708B2 (en) Removable catheter hub
CA2608714C (fr) Ensemble catheter port pour traitement extracorporel
US7794422B2 (en) Catheter port assembly for extracorporeal treatment
US6258079B1 (en) Method and systems for establishing vascular access
US7347853B2 (en) Catheter with removable extension
US5989239A (en) Method and apparatus for percutaneously accessing an implanted port
US5421814A (en) Hemodialysis infusion port and access needle
AU2001257388A1 (en) Implantable hemodialysis access device
EP1032454A1 (fr) Dispositif d'acces sous-cutane
JPH04507050A (ja) 血液の体外処理のための脈管アクセスシステム
US20030023208A1 (en) Apparatus for vascular access
US20170120000A1 (en) Central venous catheter with removable side ports
US20150196704A1 (en) Implantable high flow multi-window vascular access port catheter
EP0814865A1 (fr) Systeme d'acces vasculaire
CA2278125A1 (fr) Procedes et systemes d'acces vasculaire
CA2361039A1 (fr) Systeme d'acces et procedes faisant intervenir des canules reversibles

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 1996909798

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2222142

Country of ref document: CA

Ref country code: CA

Ref document number: 2222142

Kind code of ref document: A

Format of ref document f/p: F

WWP Wipo information: published in national office

Ref document number: 1996909798

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1996909798

Country of ref document: EP